Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. Lancet. 2022;399:1347–58. https://doi.org/10.1016/S0140-6736(21)02391-6

Vogel B, Claessen BE, Arnold S V., Chan D, Cohen DJ, Giannitsis E, et al. ST-segment elevation myocardial infarction. Nature Reviews Disease Primers 2019 5:1 [Internet]. 2019 [cited 2023 Mar 13];5:1–20. https://www.nature.com/articles/s41572-019-0090-3

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40:237–69.

Article  PubMed  Google Scholar 

Heusch G, Gersh BJ. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J. 2017;38:774–84.

CAS  PubMed  Google Scholar 

Zhao W, Zhao J, Rong J. Pharmacological modulation of cardiac remodeling after myocardial infarction. Oxidative Medicine and Cellular Longevity, 2020;2020.(1): 8815349

Leancă SA, Crișu D, Petriș AO, Afrăsânie I, Genes A, Costache AD, et al. Left ventricular remodeling after myocardial infarction: from physiopathology to treatment. Life 2022, Vol 12, Page 1111 [Internet]. 2022 [cited 2023 Mar 12];12:1111. Available from: https://www.mdpi.com/2075-1729/12/8/1111/htm

Anzai T. Inflammatory mechanisms of cardiovascular remodeling. Circ J. 2018;82:629–35.

Article  CAS  PubMed  Google Scholar 

Legallois D, et al. Definition of left ventricular remodelling following ST-elevation myocardial infarction: a systematic review of cardiac magnetic resonance studies in the past decade. Heart Failure Reviews, 2022, 1–12

Luo R, Sun X, Shen F, Design BH-D, Development undefined, 2020‏ undefined. Effects of high-dose rosuvastatin on ventricular remodelling and cardiac function in ST-segment elevation myocardial infarction‏. ncbi.nlm.nih.gov‏ [Internet]. [cited 2021 Aug 20]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520152/

Węgiel M, Interwencyjnej TR-P w K‏ undefined. Circulating biomarkers as predictors of left ventricular remodeling after myocardial infarction‏. ncbi.nlm.nih.gov‏ [Internet]. [cited 2021 Sep 8]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/pmc8039920/

Bostan M, Stătescu C, Anghel L, Biomolecules I Șerban-, 2020‏ undefined. Post-myocardial infarction ventricular remodeling biomarkers—the key link between pathophysiology and clinic‏. mdpi.com‏ [Internet]. [cited 2021 Aug 22]; Available from: https://www.mdpi.com/898930

Sai L, YanQiu Z, DongMei C, Pharmaceutical LY-TJ of, 2019‏ undefined. Effect of rosuvastatin and benazepril on matrix metalloproteinase-2, matrix metalloproteinase-9 and leukotriene B4 of patients with acute myocardial infarction‏. ajol.info‏L Sai, Z YanQiu, C DongMei, L YinJun‏Tropical Journal of Pharmaceutical Research, 2019‏•ajol.info‏ [Internet]. 2019 [cited 2023 Sep 11];18:625–30. Available from: https://www.ajol.info/index.php/tjpr/article/view/207139

Liu H, Yang Y, Yang S, Luo J, Li H, Jing L, et al. Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a ‏. Elsevier‏ [Internet]. [cited 2023 Dec 26]; Available from: https://www.sciencedirect.com/science/article/pii/S0149291813000167

Park S, Kim IC, Kim H, Cho YK, Lee CH, Hur SH. Ability of soluble ST2 to predict left ventricular remodeling in patients with acute coronary syndrome. Heart Vessels. 2022;37:173–83.

Article  PubMed  Google Scholar 

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationThe Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J [Internet]. 2018 [cited 2023 Mar 11];39:119–77. Available from: https://academic.oup.com/eurheartj/article/39/2/119/4095042

O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, De Lemos JA, et al. ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2013;2013:61.

Google Scholar 

Izawa A, et al. Assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial Infarction–ALPS-AMI Study–. Circulation Journal. 2014;79.1:161–8.

Tsutsui H. Protective effects of statins against myocardial remodeling. J Card Fail [Internet]. 2009 [cited 2023 Aug 20];15:S142. Available from: http://www.onlinejcf.com/article/S1071916409007271/fulltext

Oesterle A, Laufs U, Liao JK. Pleiotropic effects of statins on the cardiovascular system. Circ Res. 2017;120:229–43. https://doi.org/10.1161/CIRCRESAHA.116.308537.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reddy R, Chahoud G, Mehta J. Modulation of cardiovascular remodeling with statins: fact or fiction? Curr Vasc Pharmacol. 2005;3:69–79.

Article  CAS  PubMed  Google Scholar 

Chou R, Dana T, Blazina I, Daeges M, Jeanne TL. Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US Preventive Services Task Force. JAMA [Internet]. 2016 [cited 2021 Aug 22];316:2008–24. Available from: https://jamanetwork.com/journals/jama/fullarticle/2584057

Ma W, Liu W, Biology JM-C and M, 2023‏ undefined. Influencing mechanism of large-dose of atorvastatin in serum visfatin, MMP-9, and blood fat levels of patients with acute coronary syndromes‏. cellmolbiol.org‏W Ma, W Liu, J Mu‏Cellular and Molecular Biology, 2023‏•cellmolbiol.org‏ [Internet]. 2023 [cited 2023 Sep 13]; Available from: http://cellmolbiol.org/index.php/CMB/article/view/4711

Qian C, Wei B, Ding J, Wu H, Cai X, BL-TAJ of, et al. Meta-analysis comparing the effects of rosuvastatin versus atorvastatin on regression of coronary atherosclerotic plaques‏. Elsevier‏ [Internet]. [cited 2023 Dec 24]; Available from: https://www.sciencedirect.com/science/article/pii/S0002914915018378

Guo J, et al. Study on the effect of different doses of rosuvastatin on ventricular remodeling in patients with acute coronary syndrome after emergency percutaneous coronary intervention. European Review for Medical & Pharmacological Sciences. 2017, 21(19).

Lu F, Zhang J, Mou L, LI Y, Zheng Q. The clinical effects of atorvastatin versus simvastatin on levels of serum lipid, high-sensitivity C-reactive protein and ventricular remodeling in patients with acute coronary syndrome. Chinese J Geriatrics. 2017;647–9. https://doi.org/10.3760/cma.j.issn.0254-9026.2017.06.011

He W, Cao M, research ZL-D development. undefined. Effects of different doses of atorvastatin, rosuvastatin, and simvastatin on elderly patients with ST‐elevation acute myocardial infarction (AMI) after percutaneous ‏. Wiley Online Library‏W He, M Cao, Z Li‏Drug development research, 2020‏ Wiley Online Library‏. 2020;81:551https://doi.org/10.1002/ddr.21651

Liu H, Yang Y, Yang S, Luo J, Li H, Jing L, et al. Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a ‏. Elsevier‏]. [cited 2023 Dec 22]; Available from: https://www.sciencedirect.com/science/article/pii/S0149291813000167

Atorvastatin monograph for professionals - Drugs.com [Internet]. [cited 2024 Apr 1]. Available from: https://www.drugs.com/monograph/atorvastatin.html

Rosuvastatin monograph for professionals - Drugs.com [Internet]. [cited 2024 Apr 1]. Available from: https://www.drugs.com/monograph/rosuvastatin.html

El Said NO, El Wakeel LM, Khorshid H, Darweesh EAG, Ahmed MA. Impact of lipophilic vs hydrophilic statins on the clinical outcome and biomarkers of remodelling in heart failure patients: a prospective comparative randomized study. Br J Clin Pharmacol. 2021;87:2855–66.

Article  PubMed  Google Scholar 

Chitose T, Sugiyama S, Sakamoto K, Atherosclerosis HS-, 2014‏ undefined. Effect of a hydrophilic and a hydrophobic statin on cardiac salvage after ST-elevated acute myocardial infarction–a pilot study‏. Elsevier [Internet]. [cited 2023 Dec 19]; Available from: https://www.sciencedirect.com/science/article/pii/S0021915014013823

Kawano H, Yano K. Pravastatin decreases blood pressure in hypertensive and hypercholesterolemic patients receiving antihypertensive treatment. Circ J. 2006;70:1116–21.

Article  CAS  PubMed  Google Scholar 

Lee S, Yang S, Chang MJ. Antihypertensive effects of rosuvastatin in patients with hypertension and dyslipidemia: a systemic review and meta-analysis of randomized studies. PLoS One. 2021;16:e0260391. https://doi.org/10.1371/journal.pone.0260391.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alghamdi J, Alqadi A, Alharf A, Almuzzaini B, Mahmud A, Barhoumi T, et al. Blood pressure–lowering activity of statins: a systematic literature review and meta-analysis of placebo-randomized controlled trials. Eur J Clin Pharmacol. 2020;76:1745–54. https://doi.org/10.1007/s00228-020-02965-2.

Article  CAS  PubMed  Google Scholar 

Zhou Y, Qu L, University XZ-J of HM. undefined. Effects of rosuvastatin and atorvastatin on inflammatory factors and left ventricular remodeling in patients with non-ST segment elevation acute myocardial ‏. scholar.archive.org‏Y Zhou, L Qu, XL Zhu‏Journal of Hainan Medical University, 2016‏•scholar.archive.org‏ [Internet]. 2016 [cited 2023 Dec 24];22:65–8. Available from: https://scholar.archive.org/work/ukjspxi575d4xekbx6hodewswy/access/wayback/http://www.hnykdxxb.com/PDF/201613/18.pdf

刘智坚, 胡高频, 费美莹, 殷召, 时全星, 孙飞, et al. Effects of short-term high dose atorvastatin on left ventricular remodeling in patients with first time attack of anterior acute myocardial infarction. Chinese Medical Sciences Journal. 2018;33:84–90.

Khurana S, Gupta S, Bhalla H, Nandwani S, Gupta V. Comparison of anti-inflammatory effect of atorvastatin with rosuvastatin in patients of acute coronary syndrome. J Pharmacol Pharmacother. 2015;6:130–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Umrani S, Jamshed W, Rizwan A. Comparison of atorvastatin and rosuvastatin in reduction of inflammatory markers in acute coronary syndrome. Cureus. 2020, 12(11)

Kumar B, et al. Comparison of atorvastatin and rosuvastatin in reduction of inflammatory biomarkers in patients with acute coronary syndrome. Cureus. 2019, 11(6).

Wagner D, Delagardelle C, Ernens I. DR-J of cardiac, undefined. Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction‏. Elsevier‏ [Internet]. [cited 2023 Sep 9]; Available from: https://www.sciencedirect.com/science/article/pii/S1071916405008195

Guo J, ZHANG W, Zhao Q, JW-ER. undefined. Study on the effect of different doses of rosuvastatin on ventricular remodeling in patients with acute coronary syndrome after emergency percutaneous coronary ‏. europeanreview.org‏J Guo, WH ZHANG, Q Zhao, JS Wo, SL Cai‏European Review for Medical & Pharmacological Sciences, 2017‏•europeanreview.org‏ [Internet]. [cited 2023 Dec 25]; Available from: https://www.europeanreview.org/wp/wp-content/uploads/4457-4463-Rosuvastatin-on-ventricular-remodeling-in-patients-with-ACS-after-emergency-PCI.pdf

Ip C, Luk K, Yuen V, Chiang L, Chan C, KH-IH&, et al. Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: a systematic review and meta ‏. Elsevier‏ [Internet]. [cited 2023 Sep 4]; Available from: https://www.sciencedirect.com/science/article/pii/S2352906721001755

Tan R, Yu H, Han X, Liu Y, Yang X, Xia Y-L, et al. Circulating soluble suppression of tumorigenicity 2 predicts recurrence after radiofrequency ablation of persistent atrial fibrillation. Front Cardiovasc Med. 2021;8:653312.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berezin AE, Berezin AA. Adverse cardiac remodelling after acute myocardial infarction: old and new biomarkers. Disease Markers. 2020;2020(1):1215802.

Abstract 19277: Statin therapy lowers myocardial fibrosis marker sST2 in patients living with HIV | Circulation [Internet]. [cited 2024 May 27]. Available from: https://www.ahajournals.org/doi/abs/10.1161/circ.134.suppl_1.19277

DeFilippi C, Christenson R, Joyce J, Park EA, Wu A, Fitch K V, et al. Brief report: statin effects on myocardial fibrosis markers in people living with HIV. J Acquir Immune Defic Syndr [Internet]. 2018 [cited 2024 May 27];78:105–10. Available from: https://pubmed.ncbi.nlm.nih.gov/29419569/

SST2 as a predictor of statin treatment efficacy in patients with multiple myeloma - PubMed [Internet]. [cited 2024 May 27]. Available from: https://pubmed.ncbi.nlm.nih.gov/35959872/

Kavalipati N, Shah J, Ramakrishan A, Vasnawala H. Pleiotropic effects of statins. Indian J Endocrinol Metab [Internet]. 2015 [cited 2024 Jan 30];19:554. Available from: /pmc/articles/PMC4566334/

Zhang L, Zhang S, Herz YY. undefined. Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol‏. search.proquest.com‏L Zhang, S Zhang, Y Yu‏Herz, 2020‏•search.proquest.com‏ [Internet]. [cited 2023 Dec 24]; Available from: https://search.proquest.com/openview/5e3830c4e8e3fd5dc58cf24794f91138/1?pq-origsite=gscholar&cbl=38117

Schachter M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol. 2005;19:117–25. https://doi.org/10.1111/j.1472-8206.2004.00299.x.

Article  CAS  PubMed  Google Scholar 

Crouse JR. An evaluation of rosuvastatin: pharmacokinetics, clinical efficacy and tolerability. Expert Opin Drug Metab Toxicol. 2008;4:287–304. https://doi.org/10.1517/17425255.4.3.287.

Article  CAS  PubMed  Google Scholar 

Bytyci I, Bajraktari G, Bhatt D, CM-J of C. undefined. Hydrophilic vs lipophilic statins in coronary artery disease: a meta-analysis of randomized controlled trials‏. Elsevier [Internet]. [cited 2023 Dec 23]; Available from: https://www.sciencedirect.com/science/article/pii/S1933287417300715